v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue:    
Revenue $ 44,846 $ 14,381
Operating expenses:    
Cost of sales 7,809 1,247
Research and development 110,027 90,945
General and administrative 102,093 51,187
Total operating expenses: 219,929 143,379
Net operating loss (175,083) (128,998)
Interest income 5,393 98
Interest expense (7,529) (8,538)
Other income/(expense), net (277) (289)
Net loss before taxes (177,496) (137,727)
Income tax expense 282 1,208
Net loss (177,778) (138,935)
Other comprehensive gain/(loss):    
Unrealized gain/(loss) on marketable securities   (52)
Foreign currency gain 100 83
Total other comprehensive income/(loss) 100 31
Comprehensive loss, net of tax $ (177,678) $ (138,904)
Net loss per common share, basic $ (1.56) $ (1.42)
Net loss per common share, diluted $ (1.56) $ (1.42)
Weighted-average number of common shares used in net loss per common share, basic 113,872 98,069
Weighted-average number of common shares used in net loss per common share, diluted 113,872 98,069
Product revenue, net [Member]    
Revenue:    
Revenue $ 38,800 $ 12,109
Licensing and other revenue [Member]    
Revenue:    
Revenue $ 6,046 $ 2,272